Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Craniofacial Surgery|September 17, 2013
Normocephalic pancraniosynostosisElizabeth A Killion, Thomas W McEwan, Arshad R Muzaffar
Aesthetic Surgery Journal|March 26, 2015
A systematic examination of the effect of tissue glues on rhytidectomy complicationsElizabeth A Killion, Charles H Hyman, Daniel A Hatef, et al.
Endocrine Reviews|September 13, 2019
Glucose-Dependent Insulinotropic Polypeptide Receptor Therapies for the Treatment of Obesity, Do Agonists = Antagonists?Elizabeth A Killion, Shu-Chen Lu, Madeline Fort, et al.
Andrology|February 28, 2022
GIPR gene expression in testis is mouse specific and can impact male mouse fertilityElizabeth A Killion, Rajaa Hussien, Artem Shkumatov, et al.
Molecular Metabolism|March 16, 2016
Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorptionThomas A Bowman, Kayleigh R O'Keeffe, Theresa D'Aquila, et al.
Critical Care (London, England)|December 22, 2017
Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patientsGabriel Hundeshagen, David N Herndon, Karel D Capek, et al.
Cell Reports. Medicine|June 7, 2021
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeysShu-Chen Lu, Michelle Chen, Larissa Atangan, et al.
Molecular Metabolism|February 6, 2018
A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunctionElizabeth A Killion, Andrew R Reeves, Mahmoud A El Azzouny, et al.
Nature Metabolism|April 29, 2025
GIPR-Ab/GLP-1 peptide-antibody conjugate requires brain GIPR and GLP-1R for additive weight loss in obese miceClarissa M Liu, Elizabeth A Killion, Rola Hammoud, et al.
Pageof 2